Richard Malabre
Comptroller/Controller/Auditor bei AKEBIA THERAPEUTICS, INC.
Vermögen: 250 824 $ am 31.05.2024
Aktive Positionen von Richard Malabre
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 08.01.2024 | - |
Karriereverlauf von Richard Malabre
Ehemalige bekannte Positionen von Richard Malabre
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ultivue, Inc.
 Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Finanzdirektor/CFO | 01.03.2021 | 01.09.2023 |
| Treasurer | 01.03.2021 | 01.09.2023 |
Ausbildung von Richard Malabre
| Massachusetts Institute of Technology | Graduate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Comptroller/Controller/Auditor | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ultivue, Inc.
Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Richard Malabre
- Erfahrung
